STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Company

Adaptive Biotechnologies Corp

Filed

November 19, 2024

Period of Report

November 18, 2024

Accession Number

0001062993-24-019373